of different media on exopolysaccharide and biomass production by the green microalga Botryococcus braunii. J. Appl. Phycol., 26, 5, 2087– 2095, 2014.
62. You, T. and Barnett, S.M., Effect of light quality on production of extracellular polysaccharides and growth rate of Porphyridium cruentum. Biochem. Eng. J., 19, 3, 251–258, 2004.
63. Markou, G. and Nerantzis, E., Microalgae for high-value compounds and biofuels production: A review with focus on cultivation under stress conditions. Biotechnol. Adv., 31, 8, 1532–1542, 2013.
64. Raposo, M.F.d.J. et al., Bioactivity and applications of sulphated polysaccharides from marine microalgae. Mar. Drugs, 11, 1, 233–252, 2013.
65. Yoon, H.S. et al., Defining the major lineages of red algae (RHODOPHYTA) 1. J. Phycol., 42, 2, 482–492, 2006.
66. Sindhu, K.A., Prasanth, R., Thakur, V.K., Medical Applications of Cellulose and its Derivatives: Present and Future, in: Nanocellulose Polymer Nanocomposites: Fundamentals and Applications, V.K. Thakur, (Ed.), Scrivener Publishing LLC, Beverly, Mass., USA, 2014.
67. Ettenauer, M. et al., Characterization and functionalization of cellulose microbeads for extracorporeal blood purification. Cellulose, 18, 5, 1257, 2011.
68. Ye, S.H. et al., Antifouling blood purification membrane composed of cellulose acetate and phospholipid polymer. Biomaterials, 24, 23, 4143–4152, 2003.
69. Picheth, G.F. et al., Bacterial cellulose in biomedical applications: A review. Int. J. Biol. Macromol., 104, 97–106, 2017.
70. Evdokimova, L.O. et al., Hybrid drug delivery patches based on spherical cellulose nanocrystals and colloid titania—Synthesis and antibacterial properties. Nanomaterials, 8, 228, 2018.
71. Gopi, S. et al., Applications of cellulose nanofibrils in drug delivery, in: Applications of Nanocomposite Materials in Drug Delivery, Inamuddin, A.M. Asiri, A. Mohammad, (Eds.), pp. 75–95, Woodhead Publishing, Sawston, Cambridge, 2018.
72. Karimian, A. et al., Nanocrystalline cellulose: Preparation, physicochemical properties, and applications in drug delivery systems. Int. J. Biol. Macromol., 133, 850–859, 2019.
73. Lam, E. et al., Applications of functionalized and nanoparticle-modified nanocrystalline cellulose. Trends Biotechnol., 30, 5, 283–290, 2012.
74. Zhao, J. et al., Polyethylenimine-grafted cellulose nanofibril aerogels as versatile vehicles for drug delivery. ACS Appl. Mater. Interfaces, 7, 4, 2607–2615, 2015.
75. Ninan, N. et al., Pectin/carboxymethyl cellulose/microfibrillated cellulose composite scaffolds for tissue engineering. Carbohydr. Polym., 98, 1, 877–885, 2013.
76. Müller, F.A. et al., Cellulose-based scaffold materials for cartilage tissue engineering. Biomaterials, 27, 21, 3955–3963, 2006.
77. Domingues, R.M.A., Gomes, M.E., Reis, R.L., The potential of cellulose nanocrystals in tissue engineering strategies. Biomacromolecules, 15, 7, 2327–2346, 2014.
78. Dugan, J.M., Gough, J.E., Eichhorn, S.J., Bacterial cellulose scaffolds and cellulose nanowhiskers for tissue engineering. Nanomedicine, 8, 2, 287–298, 2013.
79. Hemapriya, J. et al., Chitosan and its biomedical applications, in: Marine Polysaccharides— Advances and Multifaceted Applications, S. Ahmed, and A. Soundararajan, (Eds.), p. 322, Pan Stanford Publishing, Singapore, 2018.
80. Mao, J. et al., Study of novel chitosan–gelatin artificial skin in vitro. J. Biomed. Mater. Res. Part A, 64A, 2, 301–308, 2003.
81. Parvez, S. et al., Preparation and characterization of artificial skin using chitosan and gelatin composites for potential biomedical application. Polym. Bull., 69, 6, 715–731, 2012.
82. Liu, H. et al., A study on a chitosan-gelatin-hyaluronic acid scaffold as artificial skin in vitro and its tissue engineering applications. J. Biomater. Sci. Polym. Ed., 15, 1, 25–40, 2004.
83. Peng, C.-C. et al., Composite nano-titanium oxide–Chitosan artificial skin exhibits strong wound-healing effect—An approach with anti-inflammatory and bactericidal kinetics. Macromol. Biosci., 8, 4, 316–327, 2008.
84. Dai, T. et al., Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev. Anti-Infect. Ther., 9, 7, 857–879, 2011.
85. Kong, M. et al., Antimicrobial properties of chitosan and mode of action: A state of the art review, The 16th CBL (Club des Bactéries Lactiques) Symposium, May 2009, Toulouse, France. Int. J. Food Microbiol., 144, 1, 51–63, 2010.
86. Wang, X., Du, Y., Liu, H., Preparation, characterization and antimicrobial activity of chitosan– Zn complex. Carbohydr. Polym., 56, 1, 21–26, 2004.
87. Liu, H. et al., A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing. RSC Adv., 8, 14, 7533–7549, 2018.
88. Croisier, F. and Jérôme, C., Chitosan-based biomaterials for tissue engineering, Biobased Polymers and Related Materials. Eur. Polym. J., 49, 4, 780–792, 2013.
89. Madihally, S.V. and Matthew, H.W.T., Porous chitosan scaffolds for tissue engineering. Biomaterials, 20, 12, 1133–1142, 1999.
90. Venkatesan, J. et al., Recent Advances of Alginate Biomaterials in Tissue Engineering, in: Marine Polysaccharides—Advances and Multifaceted Applications, S. Ahmed, and S. Aisverya, (Eds.), p. 322, Pan Stanford Publishing, Singapore, 2018.
91. Chen, T.-y. et al., Preparation and characterization of alginate/HACC/oyster shell powder biocomposite scaffolds for potential bone tissue engineering applications. RSC Adv., 6, 42, 35577– 35588, 2016.
92. Luo, H. et al., Porous nanoplate-like hydroxyapatite–sodium alginate nanocomposite scaffolds for potential bone tissue engineering. Mater. Technol., 32, 2, 78–84, 2017.
93. Venkatesan, J. et al., Alginate composites for bone tissue engineering: A review. Int. J. Biol. Macromol., 72, 269–281, 2015.
94. Bhatia, S.N. et al., Cell and tissue engineering for liver disease. Sci. Transl. Med., 6, 245, 245sr2, 2014.
95. Kumari, J., Karande, A.A., Kumar, A., Combined effect of cryogel matrix and temperature-reversible soluble–insoluble polymer for the development of in vitro human liver tissue. ACS Appl. Mater. Interfaces, 8, 1, 264–277, 2016.
96. Li, L., Zhang, Y., Pan, X., Preparation and Characterization of Alginate–Chitosan Microcapsule for Hepatocyte Culture, in: Cell Microencapsulation: Methods and Protocols, E.C. Opara, (Ed.), pp. 199–206, Springer New York, New York, NY, 2017.
97. Palakkan, A.A. et al., Liver tissue engineering and cell sources: Issues and challenges. Liver Int., 33, 5, 666–676, 2013.
98. Climov, M. et al., Natural Biomaterials for Skin Tissue Engineering, in: Skin Tissue Engineering and Regenerative Medicine, M.Z. Albanna, and J.H. Holmes, (Eds.), pp. 145–161, Elsevier, Amsterdam, 2016.
99. Gong, Y. et al., Preparation of alginate membrane for tissue engineering. J. Polym. Eng., 36, 4, 363, 2015.
100. Dashtdar, H. et al., Ultra-structural changes and expression of chondrogenic and hypertrophic genes during chondrogenic differentiation of mesenchymal stromal cells in alginate beads. PeerJ, 4, e1650–e1650, 2016.
101. Kurth, T. et al., Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthr. Cartil., 15, 10, 1178–1189, 2007.
102. Park, H. et al., Alginate hydrogels modified with low molecular